Cargando…

Determining the anti-coagulant-independent anti-cancer effects of heparin

Detalles Bibliográficos
Autores principales:	Solari, V, Jesudason, E C, Turnbull, J E, Yates, E A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939791/ https://www.ncbi.nlm.nih.gov/pubmed/20648011 http://dx.doi.org/10.1038/sj.bjc.6605808

Ejemplares similares

Heparin beyond anti-coagulation
por: Chen, Daohong
Publicado: (2021)

Overt and non-overt disseminated intravascular coagulation and the potential role of heparin in the COVID-19 pandemic outbreak
por: Salamanna, Francesca, et al.
Publicado: (2020)

Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2010)

Immunological effects of anti-coagulant unfractionated heparin in pregnant Chinese women with cryptic recurrent miscarriages
por: Hong, Yanli, et al.
Publicado: (2020)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Anti‐cachexia therapy should target metabolism, inflammatory cytokines, and androgens in hormone‐independent cancers
por: Lambert, Charles Paul
Publicado: (2021)

The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: May, Jori E., et al.
Publicado: (2020)

Anti-Coagulant and Antimicrobial Recombinant Heparin-Binding Major Ampullate Spidroin 2 (MaSp2) Silk Protein
por: Mulinti, Pranothi, et al.
Publicado: (2022)

Heparin-induced thrombocytopenia in a patient with colon cancer
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Heparin-induced thrombocytopenia in a patient with colon cancer
por: Koul, Ajaz Nabi, et al.
Publicado: (2013)

Hepatitis E Virus and Porcine-derived Heparin
por: Crossan, C., et al.
Publicado: (2013)

By-Products of Heparin Production Provide a Diverse Source of Heparin-like and Heparan Sulfate Glycosaminoglycans
por: Taylor, Sarah L., et al.
Publicado: (2019)

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

An Anti-Coagulation Conundrum: Implantation of Total Artificial Heart in a Patient with Heparin-Induced Thrombocytopenia Type II
por: Cios, Theodore J., et al.
Publicado: (2017)

Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
por: Han, Xiaoyun, et al.
Publicado: (2015)

Heparin induced thrombocytopenia-type 2
por: Majeed, Tanveer A.
Publicado: (2010)

Refractory hyperkalemia related to heparin abuse
por: Bawaskar, Himmatrao S., et al.
Publicado: (2014)

Heparin-induced bullous hemorrhagic dermatosis()
por: Hamdi, Douja, et al.
Publicado: (2022)

Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al.
por: Susen, Sophie, et al.
Publicado: (2020)

Heparin-binding protein in lower airway samples as a biomarker for pneumonia
por: Paulsson, Magnus, et al.
Publicado: (2021)

Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease: A reappraisal of the role of S. cerevisiae in this setting
por: Sendid, B., et al.
Publicado: (2018)

The biofunctionalization of titanium nanotube with chitosan/genipin heparin hydrogel and the controlled release of IL-4 for anti-coagulation and anti-thrombus through accelerating endothelialization
por: Yu, Wen Peng, et al.
Publicado: (2021)

Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients
por: Schoemaker, Casper G., et al.
Publicado: (2018)

Re: Heparin-induced thrombocytopenia – Type 2
por: Yagnik, Vipul D.
Publicado: (2011)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Co-expression of anti-NMDAR and anti-GAD65 antibodies. A case of autoimmune encephalitis in a post-COVID-19 patient
por: Valadez-Calderon, J., et al.
Publicado: (2022)

Co-expression of anti-NMDAR and anti-GAD65 antibodies. A case of autoimmune encephalitis in a post-COVID-19 patient()
por: Valadez-Calderon, J., et al.
Publicado: (2022)

Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia
por: Derhaschnig, U, et al.
Publicado: (2002)

Do not confuse anti-LW autoantibodies with anti-D
por: Miola, Marcos Paulo, et al.
Publicado: (2013)

Anti-Vivisection Ethics
por: Kidd, Beatrice E.
Publicado: (1912)

Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs
por: Pasquier, E, et al.
Publicado: (2013)

Using anti-platelet therapy to prevent extracorporeal membrane oxygenator thrombosis without heparin resistance and with thrombocytopenia
por: He, Huai-Wu, et al.
Publicado: (2014)

Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation
por: Shrimali, Jigar D., et al.
Publicado: (2013)

Hypertriglyceridemia-induced acute pancreatitis treatment with insutin and heparin
por: Patel, Aalok D.
Publicado: (2012)

Management of heparin resistance in an emergency cardiac surgical patient
por: Isil, Canan Tulay, et al.
Publicado: (2012)

Pseudohyperphosphatemia due to contamination with heparin: A case for caution
por: Senthilkumaran, S., et al.
Publicado: (2014)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4sjpfq1ivgrcfksol0v80u8dq2